Business Description
Cambridge Nutritional Sciences PLC
ISIN : GB00B1VCP282
Description
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals as well as supplying the point-of-care Food Detective test. The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the group. The company generates the majority of its revenue from the Health and Nutrition segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 57.22 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.19 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.55 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year Book Growth Rate | -31.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.63 | |||||
| 9-Day RSI | 21.49 | |||||
| 14-Day RSI | 29.3 | |||||
| 6-1 Month Momentum % | -25.61 | |||||
| 12-1 Month Momentum % | 7.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.13 | |||||
| Quick Ratio | 4.6 | |||||
| Cash Ratio | 3.09 | |||||
| Days Inventory | 90.03 | |||||
| Days Sales Outstanding | 80.8 | |||||
| Days Payable | 119.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.3 | |||||
| Shareholder Yield % | 0.45 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.02 | |||||
| Operating Margin % | -3.29 | |||||
| Net Margin % | 1.94 | |||||
| FCF Margin % | 2.91 | |||||
| ROE % | 1.83 | |||||
| ROA % | 1.27 | |||||
| ROIC % | 2.71 | |||||
| ROC (Joel Greenblatt) % | -11.99 | |||||
| ROCE % | -1.86 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.5 | |||||
| PE Ratio without NRI | 28.5 | |||||
| PS Ratio | 0.77 | |||||
| PB Ratio | 0.71 | |||||
| Price-to-Tangible-Book | 1.23 | |||||
| Price-to-Free-Cash-Flow | 28.5 | |||||
| Price-to-Operating-Cash-Flow | 9.5 | |||||
| EV-to-EBIT | -10.4 | |||||
| EV-to-Forward-EBIT | -10.58 | |||||
| EV-to-EBITDA | 5.72 | |||||
| EV-to-Forward-EBITDA | 7.93 | |||||
| EV-to-Revenue | 0.26 | |||||
| EV-to-Forward-Revenue | 0.36 | |||||
| EV-to-FCF | 8.36 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Graham-Number | 1.23 | |||||
| Price-to-Net-Current-Asset-Value | 2.45 | |||||
| Price-to-Net-Cash | 2.45 | |||||
| Earnings Yield (Greenblatt) % | -9.62 | |||||
| FCF Yield % | 4.15 | |||||
| Forward Rate of Return (Yacktman) % | -22.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cambridge Nutritional Sciences PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 10.585 | ||
| EPS (TTM) (€) | 0.001 | ||
| Beta | 1.89 | ||
| Volatility % | 53.1 | ||
| 14-Day RSI | 29.3 | ||
| 14-Day ATR (€) | 0.000845 | ||
| 20-Day SMA (€) | 0.026225 | ||
| 12-1 Month Momentum % | 7.02 | ||
| 52-Week Range (€) | 0.0245 - 0.05 | ||
| Shares Outstanding (Mil) | 237.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cambridge Nutritional Sciences PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cambridge Nutritional Sciences PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cambridge Nutritional Sciences PLC Frequently Asked Questions
What is Cambridge Nutritional Sciences PLC(FRA:RVKA)'s stock price today?
The current price of FRA:RVKA is €0.02. The 52 week high of FRA:RVKA is €0.05 and 52 week low is €0.02.
When is next earnings date of Cambridge Nutritional Sciences PLC(FRA:RVKA)?
The next earnings date of Cambridge Nutritional Sciences PLC(FRA:RVKA) is 2025-07-25 Est..
Does Cambridge Nutritional Sciences PLC(FRA:RVKA) pay dividends? If so, how much?
Cambridge Nutritional Sciences PLC(FRA:RVKA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers